Yüklüyor......
Venetoclax: evidence to date and clinical potential
The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...
Kaydedildi:
| Yayımlandı: | Drugs Context |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioExcel Publishing Ltd
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788387/ https://ncbi.nlm.nih.gov/pubmed/31645879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212574 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|